BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
13.69
+2.15 (18.63%)
At close: Dec 5, 2025, 4:00 PM EST
13.75
+0.06 (0.44%)
After-hours: Dec 5, 2025, 7:48 PM EST
BBOT Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$23.80
Upside
+73.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +46.09% | Dec 5, 2025 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +82.62% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +60.70% | Nov 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +82.62% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +97.22% | Sep 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +68.01% | Sep 4, 2025 |
| Wedbush | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +82.62% | Aug 18, 2025 |